Angleur, Belgium

André Renard

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Arcelormittal Investigacion Y Desarrollo, S.l., Gesval S.a., Symbiose Biomaterials S.a.. Active years: 2017.


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: André Renard: Innovator in Inorganic-Binding Peptides

Introduction

André Renard is a notable inventor based in Angleur, Belgium. He has made significant contributions to the field of quality control methods through his innovative work with inorganic-binding peptides. His research focuses on identifying and isolating inorganic entities, which has important implications for various industries.

Latest Patents

Renard holds a patent for "Inorganic-binding peptides and quality control methods using them." This invention relates to methods for quality control that utilize inorganic-binding peptides to identify inorganic entities of interest. The patent includes techniques for detecting defects or inhomogeneities on surfaces and isolating powder particles containing inorganic entities. Notably, the invention features inorganic-binding peptides with specific amino acid sequences, including MTWDPSLASPRS (SEQ ID NO: 31) and LNAAVPFTMAGS (SEQ ID NO: 32). He has 1 patent to his name.

Career Highlights

Throughout his career, André Renard has worked with several prominent organizations. He has been associated with the Université de Liège, where he contributed to academic research. Additionally, he has collaborated with Interface Enterprises and Arcelormittal Investigación y Desarrollo S.L., further enhancing his expertise in the field.

Collaborations

Renard has worked alongside talented individuals such as Christelle Vreuls and Cécile Van De Weerdt. Their collaborative efforts have contributed to advancements in the understanding and application of inorganic-binding peptides.

Conclusion

André Renard's innovative work in inorganic-binding peptides showcases his commitment to advancing quality control methods. His contributions have the potential to impact various industries significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…